Sclerostin-binding antibody
US7592429B2 · kind B2 · utility
76Cited by
42References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 25, 2006 |
| Grant date | Sep 22, 2009 |
| Priority date | — |
| Expiry date | Apr 25, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.